Medicine used for treating angina pectoris

An angina pectoris and drug technology, applied in the field of drugs for the treatment of angina pectoris, can solve problems such as side effects, poor curative effects, and drugs that cannot meet the needs of patients, and achieve quick effects.

Inactive Publication Date: 2019-04-02
龚敏
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, there are also many drugs for the treatment of angina pectoris, but most of them are not very effective, and many

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0010] The present invention will be further described in detail in conjunction with specific embodiments below.

[0011] A medicine for treating angina pectoris consisting of:

[0012] Alisma 15g, Liangmianzhen 14g, Chishao 7g, Corydalis 3g, Polygala 13g, Ophiopogon japonicus 15g, Rhodiola 21g, Qianjinzi 14g, Jinguolan 21g and Anemarrhena 4g.

[0013] As a preference, when the medicine is boiled, the ratio of the medicine to water is 1:3.

[0014] As a preference, the selected medical materials of the medicine are all dried and sterilized.

[0015] As a preference, the selected medicinal materials of the medicine are all shredded and then boiled.

[0016] The beneficial effect of the invention is that it can effectively treat angina pectoris, has quick effect, has no side effect and is suitable for people of all ages and genders.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine used for treating angina pectoris. The medicine used for treating angina pectoris is composed of 15g of oriental waterplantain rhizome, 14g of Zanthoxylum nitidum, 7g of radix paeoniae rubra, 3g of corydalis tuber, 13g of polygala root, 15g of Tuber of Dwarf Lilyturf, 21g of rhodiola root, 14g of Chinese sprangletop, 21g of Radix Tinosporae, and 4g of anemarrhena. The beneficial effects are that: the medicine can be used for treating angina pectoris effectively; effect is achieved quickly; no side effect is caused; and the medicine is suitable for both men and women of different ages.

Description

technical field [0001] The invention belongs to the field of medicines, in particular to a medicine for treating angina pectoris. Background technique [0002] Angina pectoris is a common, frequent and difficult disease of all ages. At present, there are also many drugs for treating angina pectoris, but most of them are not very effective, and many drugs will produce certain side effects. With the development of society, these drugs can no longer meet the needs of patients. Contents of the invention [0003] The technical problem to be solved by the present invention is to provide a medicine for treating angina pectoris, which can treat angina pectoris conveniently and has no side effects. [0004] The technical solution adopted in the present invention is: a medicine for treating angina pectoris, consisting of the following components: [0005] Alisma 15g, Liangmianzhen 14g, Chishao 7g, Corydalis 3g, Polygala 13g, Ophiopogon japonicus 15g, Rhodiola 21g, Qianjinzi 14g, ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): A61K36/8968A61P9/10
CPCA61K36/884A61K36/41A61K36/47A61K36/59A61K36/65A61K36/66A61K36/69A61K36/71A61K36/758A61K36/8964A61K36/8968A61K2236/331A61K2300/00
Inventor 龚敏
Owner 龚敏
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products